- HOME >
- For Researchers >
- Product Search >
- Search Result >
- #11011 Anti- Bcl-1/Cyclin D1 (5D4) Mouse MoAb
Product Search
#11011 Anti- Bcl-1/Cyclin D1 (5D4) Mouse MoAb
- Intended Use:
- Research reagents
- Application:
- WB, IHC
- Package Size1:
- 200 μg
- Note on Application Abbreviations
- WB:Western Blotting
- IHC:Immunohistochemistry
※ The product indicated as "Research reagents" in the column Intended Use cannot be used
for diagnostic nor any medical purpose.
※ The datasheet listed on this page is sample only. Please refer to the datasheet
enclosed in the product purchased before use.
Product Overview
Product Overview
Product Code | 11011 |
---|---|
Product Name | Anti- Bcl-1/Cyclin D1 (5D4) Mouse MoAb |
Intended Use | Research reagents |
Application | WB, IHC |
Immunizing antigen | recombinant Human PRAD1/cyclin D1 (E. coli) |
Source | Mouse-Mouse hybridoma |
Clone Name | 5D4 |
Subclass | IgG2a |
Purification Method | Affinity Purified with protein A |
Specificity | Cross-react with cyclin D2 |
Package Form | Lyophilized product from 1% BSA in PBS containing 0.05%NaN3 |
Storage Condition | 2 - 8℃ |
Poisonous and Deleterious Substances | Applicable |
Cartagena | Not Applicable |
Package Size 1 | 200 μg |
Remarks1 | The commercial use of products without our permission is prohibited. Please make sure to contact us and obtain permission. |
Product Description
Product Description
Bcl-1/Cyclin D1 belongs to the G1 cyclins and plays a key role in cell cycle regulation during the G1/S transition by cooperating with cyclin-dependent kinases (CDKs). Its overexpression may lead to growth advantage for tumor cells by way of cell cycle progression, and actually it has been reported in various human cancers, e.g., esophageal, breast, and bladder carcinomas. Among hematolymphoid malignancies, cyclin D1 overexpression resulting from translocational activation has also been recognized in a subset of B-chronic lymphocytic leukemia (B-CLL), multiple myeloma, splenic marginal zone lymphoma, hairy cell leukemia, and mantle cell lymphoma.